Trivium Point Advisory LLC trimmed its holdings in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 0.7% in the 2nd quarter, Holdings Channel reports. The fund owned 13,311 shares of the company’s stock after selling 94 shares during the quarter. Trivium Point Advisory LLC’s holdings in Procter & Gamble were worth $2,121,000 as of its most recent SEC filing.
A number of other large investors also recently bought and sold shares of the business. Kingstone Capital Partners Texas LLC increased its stake in shares of Procter & Gamble by 655,209.0% during the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after purchasing an additional 76,017,350 shares in the last quarter. Nuveen LLC bought a new position in Procter & Gamble during the 1st quarter valued at approximately $1,954,941,000. Price T Rowe Associates Inc. MD increased its position in Procter & Gamble by 13.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after buying an additional 2,466,308 shares in the last quarter. Invesco Ltd. raised its stake in Procter & Gamble by 19.8% during the first quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock valued at $2,299,580,000 after buying an additional 2,228,151 shares during the last quarter. Finally, Assenagon Asset Management S.A. grew its stake in shares of Procter & Gamble by 140.4% in the first quarter. Assenagon Asset Management S.A. now owns 2,663,246 shares of the company’s stock worth $453,870,000 after acquiring an additional 1,555,504 shares during the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.
Insider Activity
In other Procter & Gamble news, COO Shailesh Jejurikar sold 13,039 shares of Procter & Gamble stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $2,050,643.53. Following the sale, the chief operating officer directly owned 28,036 shares in the company, valued at approximately $4,409,221.72. The trade was a 31.74% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Gary A. Coombe sold 10,194 shares of the stock in a transaction dated Thursday, August 21st. The shares were sold at an average price of $158.16, for a total transaction of $1,612,283.04. Following the transaction, the chief executive officer directly owned 34,978 shares of the company’s stock, valued at $5,532,120.48. This trade represents a 22.57% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 120,181 shares of company stock valued at $18,918,012 in the last quarter. Company insiders own 0.20% of the company’s stock.
Procter & Gamble Price Performance
Procter & Gamble (NYSE:PG – Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, beating the consensus estimate of $1.42 by $0.06. The firm had revenue of $20.89 billion for the quarter, compared to the consensus estimate of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The company’s revenue was up 1.7% on a year-over-year basis. During the same period last year, the firm earned $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Sell-side analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were issued a $1.0568 dividend. This represents a $4.23 annualized dividend and a dividend yield of 2.8%. The ex-dividend date of this dividend was Friday, July 18th. Procter & Gamble’s payout ratio is 64.82%.
Analysts Set New Price Targets
Several research firms have recently issued reports on PG. Evercore ISI reaffirmed an “in-line” rating and issued a $170.00 price target (down previously from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. Wells Fargo & Company decreased their target price on shares of Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating for the company in a report on Thursday, September 25th. Berenberg Bank increased their price target on shares of Procter & Gamble from $152.00 to $154.00 and gave the company a “hold” rating in a report on Wednesday, September 17th. BNP Paribas restated an “outperform” rating and issued a $177.00 price objective on shares of Procter & Gamble in a report on Friday, August 15th. Finally, JPMorgan Chase & Co. reiterated a “neutral” rating and set a $170.00 target price (down from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. One research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and eight have issued a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $173.68.
Check Out Our Latest Report on Procter & Gamble
Procter & Gamble Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Tesla Earnings Loom: Bulls Eye $600, Bears Warn of $300
- What is a buyback in stocks? A comprehensive guide for investors
- Cathie Wood Buys Alibaba and Baidu: Momentum or More Value Ahead?
- Growth Stocks: What They Are, What They Are Not
- This ETF Weeds Out Small-Cap Underperformers
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.